Jane Knisely is a Program Officer in the Bacteriology and Mycology Branch of the Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Disease, NIH, where she oversees scientific programs related to antimicrobial resistance and antibacterial drug development. Specifically, Jane is the program officer for NIAID’s Antibacterial Resistance Leadership Group, a clinical trials group focused on clinical research to reduce the threat of antibacterial resistance. Jane is a member of the Trans-Atlantic Task Force on Antimicrobial Resistance and is involved in the implementation of the US Combatting Antibiotic-Resistant Bacteria (CARB) National Action Plan. She joined the government in 2007 as a Presidential Management Fellow (PMF), a program that allows trainees to rotate throughout the NIH and to pursue training and leadership development opportunities. In 2006, Jane earned a Ph.D. in Cell Biology from Washington University in St. Louis.
Dr. Knisely will be speaking at World Anti-Microbial Resistance Congress USA 2016 about ‘funding programs to incentivize pre-clinical development of antibiotics‘. This session will cover supporting the development of therapeutic alternatives to traditional antibiotics to fight antimicrobial resistance (antibodies, phage therapy, microbiome manipulation), funding for antimicrobial resistance diagnostics projects, and how these programs align with the CARB goals. To hear more from Dr. Knisely and other industry experts, attend World Anti-Microbial Resistance Congress USA 2016, held September 8-9 in Washington, DC.